TESARO Announces Participation in Three Investor Conferences

WALTHAM, Mass., Oct. 22, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three conferences are:

• The 2015 Citi Global Healthcare Conference at the New York Palace in New York City on Wednesday, November 4 and Thursday, November 5, 2015. Lonnie Moulder, CEO of TESARO and Mary Lynne Hedley, Ph.D., President and COO of TESARO, will participate in meetings with investors during this conference.  
• The Credit Suisse 24th Annual Healthcare Conference at The Phoenician in Scottsdale, Arizona on Tuesday, November 10 and Wednesday, November 11. Lonnie Moulder, CEO of TESARO and Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present on November 10 at 1:00 PM PT and will also host meetings with investors.  
• The Jefferies Autumn 2015 Global Healthcare Conference at The May Fair Hotel in London on Wednesday, November 18. Lonnie Moulder, CEO of TESARO, is scheduled to present an overview of the Company's business and development programs at 4:00 PM GMT, and will also host meetings with investors.

Live webcasts of the presentations at the Credit Suisse and Jefferies conferences will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company's website for 14 days following the conferences.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of patients with cancer.

CONTACT: For additional information, please contact:
         Jennifer Davis
         1.781.325.1116
         [email protected]

You May Also Be Interested In

• Vero Fiber and MontanaSky Unite to Create Northwest Montana's Premier Fiber Broadband Provider
• Sunny Creek Modulars Expands Turnkey Accessory Dwelling Unit Solutions to Meet Growing Regional Housing Demand
• Did The White House And Attorney General Ignore Federal Intel About Marijuana Diversion Through State Licensed Markets?